Anderson Karen M. — SEC Form 4 filings

SEC reporting owner CIK 1762176. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2024-02-02 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Centessa Pharmaceuticals plc (CNTA)Chief People Officer1114 legs · 461,031 sh · $11,237,94538

Form 4 filings — Anderson Karen M.

FiledFormIssuerReported transactionsSource
2026-06-244Centessa Pharmaceuticals plc (CNTA)Disposition to issuer (D): 62,085 · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 28,336 (derivative) · Disposition to issuer (D): 83,924 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 117,000 (derivative)EDGAR
2026-03-274Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 41,076 @ $8.01 · Sale (S): 41,076 @ $30.12 · Option exercise (M): 41,076 (derivative) @ $0EDGAR
2026-03-184Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 64,768 @ $4.01 · Sale (S): 64,768 @ $28.21 · Option exercise (M): 10,043 @ $4.01 · Sale (S): 10,043 @ $28.10 · Option exercise (M): 64,768 (derivative) @ $0 · Option exercise (M): 10,043 (derivative) @ $0EDGAR
2026-03-164/ACentessa Pharmaceuticals plc (CNTA)Option exercise (M): 94,224 @ $4.01 · Option exercise (M): 15,174 @ $3.85 · Sale (S): 107,961 @ $26.15 · Sale (S): 12,068 @ $27.13 · Option exercise (M): 94,224 (derivative) @ $0 · Option exercise (M): 15,174 (derivative) @ $0EDGAR
2026-03-134Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 109,398 @ $4.01 · Sale (S): 107,961 @ $26.15 · Sale (S): 12,068 @ $27.13 · Option exercise (M): 109,398 (derivative) @ $0EDGAR
2026-02-034Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 10,606 @ $24.57 · Grant/award (A): 29,000 @ $0 · Grant/award (A): 117,000 (derivative) @ $0EDGAR
2025-02-104Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 30,526 @ $4.01 · Sale (S): 30,526 @ $19.03 · Option exercise (M): 429 @ $4.01 · Sale (S): 429 @ $18.99 · Option exercise (M): 30,526 (derivative) @ $0 · Option exercise (M): 429 (derivative) @ $0EDGAR
2025-02-044Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 10,732 @ $16.92 · Sale (S): 6,471 @ $16.86 · Grant/award (A): 120,000 (derivative) @ $0EDGAR
2024-12-174Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 5,876 @ $3.85 · Sale (S): 5,876 @ $17.01 · Option exercise (M): 10,624 @ $3.85 · Sale (S): 10,624 @ $17.32 · Option exercise (M): 5,876 (derivative) @ $0 · Option exercise (M): 10,624 (derivative) @ $0EDGAR
2024-03-264Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 25,010 @ $4.01 · Option exercise (M): 19,990 @ $3.85 · Sale (S): 29,995 @ $11.66 · Sale (S): 21,165 @ $12.21 · Option exercise (M): 25,010 (derivative) @ $0 · Option exercise (M): 19,990 (derivative) @ $0EDGAR
2024-02-024Centessa Pharmaceuticals plc (CNTA)Grant/award (A): 31,250 @ $0 · Tax withholding (F): 7,265 @ $8.19 · Grant/award (A): 125,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1762176 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →